<DOC>
	<DOC>NCT02854046</DOC>
	<brief_summary>Calciphylaxis, also called Calcific Uremic Arteriolopathy (CUA) is a lethal affection mostly affecting patient in end stage renal disease. The survival rate is described around 20 to 46% at one year. Clinical presentation is very painful skin lesions with ulceration mostly located on the trunk or thigh. Current knowledge about physiopathology, diagnostic practice and therapeutic is very limited. Actually there is no European study about calciphylaxis and risk factors, diagnostic practice and outcome factors.</brief_summary>
	<brief_title>Calciphylaxis : Population, Risk Factors, Diagnostic Practice, Therapeutic and Outcome</brief_title>
	<detailed_description />
	<mesh_term>Calciphylaxis</mesh_term>
	<criteria>patients ≥ 18 years with chronic renal failure with Glomerular Filtration Rate &lt; 30ml/min/1,73m² diagnosis of calciphylaxis between 2006 and 2016 living in the Regions of Bretagne, Pays de la Loire, PoitouCharentes or Centre Val de Loire. realized biopsy in favor of differential diagnosis significant arterial lesion of lesion area or differential diagnosis more valid if the diagnosis is not based on the following criteria: 3 clinical criteria or 2 clinical criteria and biopsy in favor, criteria which are : Patient in chronic hemodialysis or stade 4 chronic kidney disease At least 2 painful sores and hardly curable with concomitant painful purpura Sore and purpura localisation in trunk, extremities and penis.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>calcific uremic arteriolopathy</keyword>
	<keyword>case-control study</keyword>
	<keyword>cohort study</keyword>
</DOC>